(Z)-2-(3-((6-(p-tolyloxy)hexyl)oxy)benzylidene)-6,7-dihydro-5H-imidazo[2,1-b][1,3]thiazin-3(2H)-one

ID: ALA4174825

PubChem CID: 145951064

Max Phase: Preclinical

Molecular Formula: C26H30N2O3S

Molecular Weight: 450.60

Molecule Type: Small molecule

Associated Items:

This compound is not in our inventory system

Names and Identifiers

Canonical SMILES:  Cc1ccc(OCCCCCCOc2cccc(/C=C3\N=C4SCCCN4C3=O)c2)cc1

Standard InChI:  InChI=1S/C26H30N2O3S/c1-20-10-12-22(13-11-20)30-15-4-2-3-5-16-31-23-9-6-8-21(18-23)19-24-25(29)28-14-7-17-32-26(28)27-24/h6,8-13,18-19H,2-5,7,14-17H2,1H3/b24-19-

Standard InChI Key:  FXURBPTVRHGYKQ-CLCOLTQESA-N

Molfile:  

     RDKit          2D

 32 35  0  0  0  0  0  0  0  0999 V2000
   14.9082  -24.8995    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.3166  -25.6114    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   16.1379  -25.6116    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.5471  -26.3242    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.3677  -26.3247    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.7773  -25.6125    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.3645  -24.8982    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.5453  -24.9011    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.7707  -24.1850    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   18.5921  -24.1823    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   19.0775  -24.8427    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   19.0731  -23.5123    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   19.8553  -23.7662    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   19.8559  -24.5857    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   20.5626  -24.9906    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
   21.2690  -24.5847    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   21.2684  -23.7652    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   20.5614  -23.3516    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   18.8125  -22.7364    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   14.0868  -24.8993    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.6743  -24.1873    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.8530  -24.1871    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.4446  -23.4752    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.8533  -22.7676    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.6746  -22.7678    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   14.0875  -22.0561    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.9098  -22.0603    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.3184  -21.3494    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.9100  -20.6365    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.0844  -20.6389    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.6753  -21.3504    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.3178  -19.9242    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  2  0
  4  5  1  0
  5  6  2  0
  6  7  1  0
  7  8  2  0
  8  3  1  0
  7  9  1  0
  9 10  2  0
 10 11  1  0
 11 14  2  0
 13 12  1  0
 12 10  1  0
 13 14  1  0
 13 18  1  0
 14 15  1  0
 15 16  1  0
 16 17  1  0
 17 18  1  0
 12 19  2  0
  1 20  1  0
 20 21  1  0
 21 22  1  0
 22 23  1  0
 23 24  1  0
 24 25  1  0
 25 26  1  0
 26 27  2  0
 27 28  1  0
 28 29  2  0
 29 30  1  0
 30 31  2  0
 31 26  1  0
 29 32  1  0
M  END

Alternative Forms

  1. Parent:

    ALA4174825

    ---

Associated Targets(Human)

GPR18 Tchem N-arachidonyl glycine receptor (432 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
GPR55 Tclin G-protein coupled receptor 55 (1594 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CNR1 Tclin Cannabinoid CB1 receptor (20913 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CNR2 Tchem Cannabinoid CB2 receptor (16942 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 450.60Molecular Weight (Monoisotopic): 450.1977AlogP: 5.69#Rotatable Bonds: 10
Polar Surface Area: 51.13Molecular Species: NEUTRALHBA: 5HBD:
#RO5 Violations: 1HBA (Lipinski): 5HBD (Lipinski): #RO5 Violations (Lipinski): 1
CX Acidic pKa: CX Basic pKa: CX LogP: 5.87CX LogD: 5.87
Aromatic Rings: 2Heavy Atoms: 32QED Weighted: 0.34Np Likeness Score: -1.03

References

1. Schoeder CT, Kaleta M, Mahardhika AB, Olejarz-Maciej A, Łażewska D, Kieć-Kononowicz K, Müller CE..  (2018)  Structure-activity relationships of imidazothiazinones and analogs as antagonists of the cannabinoid-activated orphan G protein-coupled receptor GPR18.,  155  [PMID:29902723] [10.1016/j.ejmech.2018.05.050]

Source